Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

San Diego’s Science & Tech Community on the Front Lines of COVID-19 Innovation
Illustrated portrait of Patrick ONeill, Head of Partnerships and Investor Relations of Model Medicines

Patrick ONeill

Head of Partnerships & Investor Relations

San Diego’s science and tech community is rising to the occasion to help fight the novel coronavirus. Below is a look at several ongoing efforts by local innovative companies, research institutions, and organizations that are developing test kits, vaccines, ventilators, hand sanitizers, real-time dashboards, and more.Model Medicines harnessing the predictive prowess of its AI Drug Discovery Platform to repurpose FDA approved drugs that may serve as a potential therapeutics to prevent individuals from being infected and/or treat individuals infected with the novel coronavirus.

This article originally appeared on Fresh Brewed Tech, prior to the rebrand of Repurpose.AI to Model Medicines, read the full article here.